VJVirtual | Molecular testing in thoracic oncology

Howard West, MD, City Of Hope Comprehensive Cancer Center, Duarte, CA, comments the importance of molecular testing in thoracic oncology, particular for patients with advanced non-squamous non-small cell lung cancer (NSCLC). Dr West additionally discusses whether molecular testing should be carried out routinely for patients with early-stage lung cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.